Theranexus Société Anonyme (ALTHX.PA)
- Previous Close
1.0300 - Open
1.0350 - Bid --
- Ask --
- Day's Range
1.0200 - 1.0500 - 52 Week Range
0.6300 - 2.2350 - Volume
3,262 - Avg. Volume
35,714 - Market Cap (intraday)
8.166M - Beta (5Y Monthly) 2.34
- PE Ratio (TTM)
-- - EPS (TTM)
-0.8900 - Earnings Date Apr 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Theranexus Société Anonyme, a biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders. It is involved in the development of Batten-1, an initial drug candidate currently under Phase ½ clinical study for Batten disease. The company was founded in 2013 and is headquartered in Lyon, France.
www.theranexus.comRecent News: ALTHX.PA
Performance Overview: ALTHX.PA
Trailing total returns as of 5/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALTHX.PA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALTHX.PA
Valuation Measures
Market Cap
8.17M
Enterprise Value
6.90M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
3.62
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
319k
Net Income Avi to Common (ttm)
-6.83M
Diluted EPS (ttm)
-0.8900
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--